Arvinas' ARV-102 reduced LRRK2 protein in a Phase 1 trial, showing promising safety and pharmacodynamic outcomes for Parkinson's and PSP treatment.

It is shaping up to be another ugly day for bank stocks around the world. JPMorgan Chase, Bank of America, Morgan Stanley and ...

The so-called Magnificent Seven stocks don’t seem so magnificent these days after new tariffs from the Trump administration ...

Fears of a global recession hit mining companies. Shares ...

Retail investors bought $4.7 billion in stocks on Thursday, the highest level over the past decade, JPMorgan said in a note ...

OPEC’s planned production hikes could make a bad situation worse for oil. Natural gas stocks may fare much better.

"Don't panic. The headlines — and the market — change quickly." As for specific investment considerations, stocks are often ...

The stock market plunge has more to do with the surprise emergence of China’s DeepSeek artificial intelligence tool earlier ...

Investors, businesses and consumers all seem terrified of how President Trump's tariffs could upend the global economy.

In this piece, we will look at the stocks Jim Cramer recently discussed.

Wall Street faced another brutal selloff on Friday, with major US stock indexes suffering their worst two-day decline since ...

Not even a better-than-expected report on the U.S. job market was enough to stop the slide as the Nasdaq fell into bear ...